journal cover

Interactions between cardioactive drugs and antidepressants

European Journal of Clinical Pharmacology

Jan 1, 1977

G Cocco, C Agué

PMID: 328290

Abstract

The most important cardiovascular interactions between cardioactive drugs and monoamino-oxidase inhibitors or tricyclic antidepressants are reviewed. Post-ganglion blocking agents (e.g., guanethidine), clonidine, reserpine, and alpha-methyl-dopa should not be used in patients needing an...read more

Mentioned in this Paper

Cardiac Depressants
Tricyclic Antidepressive Agents
Antihypertensive Agents
Thymoleptics
Drug Interactions
RIMA (Reversible Inhibitor of Monoamine Oxidase A)
Electrocardiographic Recorders
Heart
Heart Diseases
Hemodynamics
Paper Details
References

Interactions between cardioactive drugs and antidepressants

European Journal of Clinical Pharmacology

Jan 1, 1977

G Cocco, C Agué

PMID: 328290

DOI:

Abstract

The most important cardiovascular interactions between cardioactive drugs and monoamino-oxidase inhibitors or tricyclic antidepressants are reviewed. Post-ganglion blocking agents (e.g., guanethidine), clonidine, reserpine, and alpha-methyl-dopa should not be used in patients needing an...read more

Mentioned in this Paper

Cardiac Depressants
Tricyclic Antidepressive Agents
Antihypertensive Agents
Thymoleptics
Drug Interactions
RIMA (Reversible Inhibitor of Monoamine Oxidase A)
Electrocardiographic Recorders
Heart
Heart Diseases
Hemodynamics
Paper Details
References
/papers/interactions-between-cardioactive-drugs-and/328290